Legal THC Limits: Why Lab Testing Is Essential in B2B CBD

Laboratory evidence is a commercial safeguard

A THC result is meaningful only when the report relates to the batch being purchased and the correct product rules. Professional CBD buyers need to check the measurement, units and test scope, rather than relying on a general “legal THC” statement from a supplier.

A certificate of analysis (COA) is the key document for this purpose. It should be connected to the relevant batch, issued by an identifiable laboratory and reviewed alongside the supplier’s product information. For a CBD wholesaler, requesting and organising these documents is part of ordinary CBD quality control instead of an optional administrative task.

This matters at every stage of the supply chain. A smoke shop may need to answer a customer query, an e-commerce retailer may be asked for product documentation, and a distributor may need to verify a new bulk delivery before splitting it into smaller professional orders. Without a current batch-level record, a business has limited grounds for assessing whether the product description remains accurate.

The French 0.3% Delta-9-THC threshold

For France, the applicable legal THC threshold for CBD flowers, resin and derived products is 0.3% Delta-9-THC. The 0.3% figure appears in the French order of 30 December 2021. Other requirements depend on the product and its intended use.

The distinction is commercially important because visual appearance, aroma or a supplier’s general reputation cannot establish the THC content of a particular batch. Compliant CBD flowers require analytical verification, especially when a business is purchasing by the kilo, receiving a restock from a new source, or preparing stock for several retail outlets.

France’s Conseil d'État ruled on 29 December 2022, that the ban on retail sales of raw CBD flowers and leaves below the applicable THC threshold could not stand. That ruling did not remove the need for professional diligence. A retailer still needs to ensure that the products it places on the market meet the conditions applicable to the batch and product format concerned.

Why a stated percentage is not sufficient

A cannabinoid percentage displayed on a list, invoice or label may be useful commercial information, but it is not a substitute for an analysis report. Businesses should be able to match a COA to a lot or batch reference and check that the document relates to the product actually delivered.

A practical review can include:

• the batch or lot identifier and its link to the delivered goods;
• the laboratory name, report date and analytical method where stated;
• the Delta-9-THC result and the way the result is expressed;
• the product format tested, such as flower, resin or e-liquid;
• the consistency between the report, packaging information and commercial documentation.

These checks do not create a guarantee of compliance, but they make it easier to identify missing or inconsistent documentation before stock reaches downstream resellers.

Product format changes the compliance questions

CBD compliance cannot be reduced to a single THC figure. The product category affects the documents to request, the claims to avoid and the rules that may apply in the market where the goods will be sold.

In France, raw CBD flowers and resin intended for non-ingestible use, e-liquids and cosmetics remain permitted subject to the 0.3% Delta-9-THC threshold and other applicable requirements. Each format still requires careful presentation: product labels, traceability records and commercial claims should match the item’s intended use.

For ingestible CBD, check the specific ingredient’s Novel Food authorisation and the intended conditions of use before purchasing. A supplier listing or batch analysis is not evidence of permission to market a food. French enforcement of unauthorised CBD foods was reiterated by the agriculture ministry in May 2026.

Confirm the VAT treatment for the particular goods and transaction before using the quote in a margin calculation. Keep the invoice, product description and supporting classification together, and resolve any unexpected rate with your accountant.

Reading a COA as part of supplier due diligence

A COA is most useful when it forms part of a broader supplier-review process. Professional buyers should compare it with the purchase order, delivery note, invoice and label artwork where relevant. This creates a clearer record of what was ordered, what was received and what documentation supported the sale.

For recurring wholesale orders, it is sensible to ask whether new reports are available when a batch changes. A report linked to an earlier lot does not necessarily describe later stock, even if the product name and visual presentation are similar. This is particularly relevant for bulk CBD flowers and resin, where batch turnover can be faster than a retailer’s product-page updates.

A reliable CBD supplier should be able to explain how lot references are managed and provide documentation in a format professional buyers can retain. At Abican, the practical question is not whether an analysis exists, but whether a reseller can connect the available document to the stock it receives and markets.

Questions worth raising before a wholesale order

Before confirming a new line, a buyer can ask focused questions that support traceability without turning the process into an abstract checklist:

• Which batch does this COA cover, and is that batch currently available?
• Does the report identify Delta-9-THC separately from other cannabinoid measurements?
• Can the product’s lot reference be traced through the invoice and delivery documentation?
• Has the product format changed since the report was issued?
• Which market is the item intended for, and have local restrictions been checked for that market?

These questions are especially relevant for businesses operating across borders. France and EU rules should not be assumed to apply unchanged in another jurisdiction. When goods are sold into a different country, the buyer should verify the current local framework instead of relying on a French threshold or product classification.

High-risk cannabinoids require constant regulatory monitoring

A professional assortment also needs a clear approach to semi-synthetic and hydrogenated cannabinoid derivatives. In France, H4CBD, H2CBD, THCP, HHC, HHC-O, HHCP and related derivatives have been classified as narcotics by the ANSM since 2023 and 2024.

Their production, sale, possession and use are illegal in France. This is not a stable product opportunity for a retailer, distributor or white-label project. It is a regulatory-risk area that requires particular caution and up-to-date verification before any commercial decision is considered.

A COA cannot resolve a prohibited-product issue. Laboratory testing can help identify a composition, but analytical documentation does not convert a restricted substance into an authorised product. Buyers should separate the question of chemical identity from the separate question of whether a product may lawfully be supplied in the intended market.

Building a documented restocking process

The most resilient businesses treat documentation as part of purchasing and restocking, not as a file requested only after a problem arises. Keeping COAs by batch, recording supplier correspondence and checking that labels match current stock can make a later review far more manageable.

For retailers using a white-label or private-label model, this discipline is particularly important because their own brand appears on the finished presentation. For dropshipping arrangements, clear responsibility for product documentation should also be established before listings go live. The same principle applies whether a business orders a small minimum order quantity or negotiates tiered pricing for larger volumes.

Abican can be assessed, like any professional supplier, on the clarity and consistency of the documents available for its selection. Buyers should retain their own records and review the requirements applicable to their sales channels, product formats and target markets.

This information is provided for general informational purposes only and does not constitute legal, tax or regulatory advice. Professional buyers should verify current requirements with a qualified advisor or the relevant competent authority before making commercial decisions.